Top Markets
#1 DogBull DogBull +105.14%
#2 ADO Protocol ADO Protocol +49.66%
#3 Siacoin Siacoin +45.17%
#4 MarsCoin MarsCoin +32.61%
#5 Ontology Gas Ontology Gas +23.11%
#6 UnifAI Network UnifAI Network +22.34%
#7 Glidr Glidr +22.29%
#8 Useless Coin Useless Coin +22.23%
#9 Falcon Finance Falcon Finance +17.76%
#10 Apertum Apertum +15.49%
Coin of the day
DogBull DogBull
Instellingen
Taal
DUTCH
Valuta
USD
Thema
AbClon Inc. AbClon Inc.

AbClon Inc.

174900
Rang in aandelen #15850
Founded in Seoul, South Korea, in 2010, AbClon Inc. is a biopharmaceutical... Founded in Seoul, South Korea, in 2010, AbClon Inc. is a biopharmaceutical company engaged in the discovery and development of antibody-based drugs, with operations spanning South Korea and Sweden. The firm's developmental pipeline encompasses therapies derived from distinct technological platforms: the NEST platform addresses breast and gastric cancers; the AffiMab platform targets colon cancer and various autoimmune conditions; and the CAR-T platform is engineered for hematologic and ovarian cancers.
Aandeelprijs
$16.42
Marktkapitalisatie
$327.24M
Verandering (1 dag)
-3.46%
Verandering (1 jaar)
129.62%
Land
KR
Handel AbClon Inc. (174900)

Categorie

Healthcare
Dividendrendementgeschiedenis voor AbClon Inc. (174900)
Het dividendrendement (TTM) van AbClon Inc. (aandelsymbool: 174900) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van AbClon Inc. (174900) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.48%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH